News & Resources
NeuroCog Trials News
2012
NEUROCOG TRIALS RECEIVES $1.2M GRANT FROM THE NATIONAL INSTITUTES OF HEALTH pdf
2011
NEUROCOG TRIALS CAPTURES VIDEO RECORDINGS OF NEUROCOGNITIVE TESTING IN A MULTINATIONAL CLINICAL TRIAL pdf
NEUROCOG TRIALS APPOINTS INDUSTRY EXECUTIVE MICHAEL HUFFORD, PH.D. TO CHIEF OPERATING OFFICER pdf
2010
NEUROCOG TRIALS CEO PRESENTS LATEST DATA USING STATE OF THE ART COGNITION BATTERY IN SCHIZOPHRENIA CLINICAL TRIAL pdf
NEUROCOGNITIVE RATER TRAINING AND DATA REVIEW RESULTS COME TO FRUITION IN LARGE ALZHEIMER’S DISEASE CLINICAL TRIAL pdf
2009
EAGLE TRIAL SIGNALS BREAKTHROUGH IN TREATMENT OF SCHIZOPHRENIA pdf
2008
NATIONAL INSTITUTE OF MENTAL HEALTH AWARDS NEUROCOG TRIALS SMALL BUSINESS INNOVATIVE RESEARCH GRANT pdf
THE MATRICS CONSENSUS COGNITIVE BATTERY (MCCB) IS CHOSEN FOR LARGE PHARMACEUTICAL CLINICAL TRIAL pdf
2007
NEUROCOG TRIALS’ BRIEF ASSESSMENT OF COGNITION (BAC) IS USED AS AN OUTCOME MEASURE FOR APPROVED RESTLESS LEG SYNDROME THERAPY pdf
2006
NEUROCOG TRIALS DEVELOPS NOVEL INTERVIEW-BASED MEASURE OF COGNITION IN SCHIZOPHRENIA pdf
NEUROCOG TRIALS SUPPORTS THE FIRST CLINICAL TRIAL USING THE MATRICS CONSENSUS COGNITIVE BATTERY pdf